Legal Representation
Attorney
GLENN A GUNDERSEN
USPTO Deadlines
Application History
47 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 31, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 30, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 30, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 30, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 30, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 4, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 10, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 10, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 4, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 15, 2024 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| Oct 15, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 6, 2024 | CFRC | R | SUBSEQUENT FINAL REFUSAL WRITTEN | Loading... |
| Sep 6, 2024 | GNS1 | O | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | Loading... |
| Sep 6, 2024 | GNSF | O | SUBSEQUENT FINAL EMAILED | Loading... |
| Jul 15, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Jul 15, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 15, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 3, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| May 3, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| May 3, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 3, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jan 26, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Jan 26, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 29, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Dec 29, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Dec 29, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Dec 6, 2023 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Dec 6, 2023 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Dec 6, 2023 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Dec 5, 2023 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Aug 28, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Aug 28, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Aug 25, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 25, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 25, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 5, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jun 5, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jun 5, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Apr 13, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 12, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 12, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 12, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 12, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 12, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 27, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 30, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 27, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and development in the field of cancer and autoimmune disease; pharmaceutical drug development and discovery services in the field of cancer and autoimmune disease; scientific research in the field of pharmaceuticals; providing scientific research information in the field of pharmaceuticals; none of the foregoing relating to gastrointestinal issues
Additional Information
Design Mark
The mark consists of the stylized word "ROME" in black with a yellow shadow connected to the left side of the letter "O" on top of the word "THERAPEUTICS" in black. The letter "R" in "ROME" is incomplete and does not include the left, vertical segment of the letter.
Color Claim
The color(s) black and yellow is/are claimed as a feature of the mark.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"